TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
VCEL

Vericel Corp Ord

Healthcare · Biotechnology

40.20$ +1.7% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement VCEL
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+77.7% +6.3% +17.5% +42.1% +29.7% +5.4% +25.8% +5.2% +20.2% +20.1% +16.5%
+53.1% +6.9% +7.2% +5.9% +16.8% +6.3% +25.6% +8.8% +13.5% +5.1% +8.5%
+114.7% +5.6% +28.7% +74.8% +36.8% +4.9% +25.9% +3.5% +23.5% +26.9% +19.5%
-11.2% -19.0% -15.4% +5.1% +123.5% -57.2% +25.1% +22.4% +5.5% +17.8% +11.2%
+63.2% +21.8% +30.0% +37.6% +24.8% +12.6% +41.8% +9.5% +9.5% +22.0% +16.9%
+18.1% +3.2% +13.8% +28.9% +46.2% -10.6% +39.1% +11.4% +12.0% +18.0% +16.1%
-431.1% +144.4%
+50.0% +3,388.9% +252.5% +56.5% -99.5% -25.0% -33.3% +9,050.0% +63.9% +2.3% +153.4%
-349.1% +65.3%
-57.7% +201.0% -152.2% -161.7% +12.9% -81.8% +480.4%
-360.9% +59.4%
-184.9% +480.6% +82.2%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?